HGHCX Mutual Fund

NAV$27.07
Showing 10 of 84 holdings(as of Jan 31, 2026)Top 10 Weight: 47.48%
#TickerNameWeightSharesMkt ValueShare ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company13.12%105,506$109.43M-14.8KHealth CarePharmaceuticals
2MRKMerck & Co. Inc.5.74%434,365$47.90M+41.6KHealth CarePharmaceuticals
3JNJJOHNSON AND JOHNSON5.07%186,167$42.31MProProPro
4UNHUnited Health Group4.64%134,871$38.70MProProPro
5ABBVAbbvie Inc Health Care3.84%143,697$32.05MProProPro
6ISRGIntuitive Surgical Inc - Common3.51%58,069$29.28MProProPro
7DHRDanaher Corporation3.06%116,573$25.52MProProPro
8ABTAbbott Laboratories2.95%225,393$24.64MProProPro
9EWEdwards Lifesciences Corp2.83%290,008$23.60MProProPro
10CORCencora Inc2.72%63,164$22.69MProProPro
See the other 74 holdings of HGHCX
Every position with sector, industry and share changes, as reported Jan 31, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

Top Holdings Themes

PharmaceuticalsBiotechnologyLife Sciences ToolsSemiconductorsAging PopulationMedical DevicesHealth InsuranceManaged CareDigital HealthHealth & WellnessImmunologyRobotics & AutomationFood InnovationCardiologyAsset Management

HGHCX Mutual Fund Top Holdings

HGHCX holdings top 10 positions. The top 10 holdings account for 47.5% of the fund, led by Eli Lilly And Company at 13.1%, Merck & Co. Inc. at 5.7%, JOHNSON AND JOHNSON at 5.1%.

HGHCX portfolio concentration is moderate, with the top 10 representing 47.5% of total assets. The largest sector exposure is Health Care at 84.0%.

HGHCX sector allocation provides a detailed breakdown. HGHCX overlap tool shows how holdings compare to other funds in your portfolio.